215 related articles for article (PubMed ID: 15082024)
21. Pharmacodynamic properties of leukotriene receptor antagonists.
Nicosia S
Monaldi Arch Chest Dis; 1999 Jun; 54(3):242-6. PubMed ID: 10441979
[TBL] [Abstract][Full Text] [Related]
22. A kinetic binding study to evaluate the pharmacological profile of a specific leukotriene C(4) binding site not coupled to contraction in human lung parenchyma.
Ravasi S; Capra V; Mezzetti M; Nicosia S; Rovati GE
Mol Pharmacol; 2000 Jun; 57(6):1182-9. PubMed ID: 10825389
[TBL] [Abstract][Full Text] [Related]
23. Differential signaling defects associated with the M201V polymorphism in the cysteinyl leukotriene type 2 receptor.
Brochu-Bourque A; Véronneau S; Rola-Pleszczynski M; Stankova J
J Pharmacol Exp Ther; 2011 Feb; 336(2):431-9. PubMed ID: 20966037
[TBL] [Abstract][Full Text] [Related]
24. Functional characterization of cysteinyl leukotriene CysLT(2) receptor on human coronary artery smooth muscle cells.
Kamohara M; Takasaki J; Matsumoto M; Matsumoto Si ; Saito T; Soga T; Matsushime H; Furuichi K
Biochem Biophys Res Commun; 2001 Oct; 287(5):1088-92. PubMed ID: 11587533
[TBL] [Abstract][Full Text] [Related]
25. The murine cysteinyl leukotriene 2 (CysLT2) receptor. cDNA and genomic cloning, alternative splicing, and in vitro characterization.
Hui Y; Yang G; Galczenski H; Figueroa DJ; Austin CP; Copeland NG; Gilbert DJ; Jenkins NA; Funk CD
J Biol Chem; 2001 Dec; 276(50):47489-95. PubMed ID: 11591709
[TBL] [Abstract][Full Text] [Related]
26. Human T(H)2 cells respond to cysteinyl leukotrienes through selective expression of cysteinyl leukotriene receptor 1.
Parmentier CN; Fuerst E; McDonald J; Bowen H; Lee TH; Pease JE; Woszczek G; Cousins DJ
J Allergy Clin Immunol; 2012 Apr; 129(4):1136-42. PubMed ID: 22391114
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of cysteinyl leukotrienes in human endothelial cells: subcellular localization and autocrine signaling through the CysLT2 receptor.
Carnini C; Accomazzo MR; Borroni E; Vitellaro-Zuccarello L; Durand T; Folco G; Rovati GE; Capra V; Sala A
FASEB J; 2011 Oct; 25(10):3519-28. PubMed ID: 21753081
[TBL] [Abstract][Full Text] [Related]
28. Targeted gene disruption reveals the role of the cysteinyl leukotriene 2 receptor in increased vascular permeability and in bleomycin-induced pulmonary fibrosis in mice.
Beller TC; Maekawa A; Friend DS; Austen KF; Kanaoka Y
J Biol Chem; 2004 Oct; 279(44):46129-34. PubMed ID: 15328359
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the human cysteinyl leukotriene CysLT1 receptor.
Lynch KR; O'Neill GP; Liu Q; Im DS; Sawyer N; Metters KM; Coulombe N; Abramovitz M; Figueroa DJ; Zeng Z; Connolly BM; Bai C; Austin CP; Chateauneuf A; Stocco R; Greig GM; Kargman S; Hooks SB; Hosfield E; Williams DL; Ford-Hutchinson AW; Caskey CT; Evans JF
Nature; 1999 Jun; 399(6738):789-93. PubMed ID: 10391245
[TBL] [Abstract][Full Text] [Related]
30. The cysteinyl leukotriene receptors.
Evans JF
Prostaglandins Leukot Essent Fatty Acids; 2003; 69(2-3):117-22. PubMed ID: 12895594
[TBL] [Abstract][Full Text] [Related]
31. Characterization of specific binding sites for cysteinyl leukotrienes in sheep lung.
Metters KM; Gareau Y; Lord A; Rochette C; Sawyer N
J Pharmacol Exp Ther; 1994 Jul; 270(1):399-406. PubMed ID: 8035338
[TBL] [Abstract][Full Text] [Related]
32. The ACh-induced contraction in rat aortas is mediated by the Cys Lt1 receptor via intracellular calcium mobilization in smooth muscle cells.
Mazzetti L; Franchi-Micheli S; Nistri S; Quattrone S; Simone R; Ciuffi M; Zilletti L; Failli P
Br J Pharmacol; 2003 Feb; 138(4):707-15. PubMed ID: 12598425
[TBL] [Abstract][Full Text] [Related]
33. Cysteinyl leukotriene receptor CysLT1 as a novel therapeutic target for allergic rhinitis treatment.
Shirasaki H
Expert Opin Ther Targets; 2008 Apr; 12(4):415-23. PubMed ID: 18348678
[TBL] [Abstract][Full Text] [Related]
34. Cysteinyl leukotriene 2 receptor on dendritic cells negatively regulates ligand-dependent allergic pulmonary inflammation.
Barrett NA; Fernandez JM; Maekawa A; Xing W; Li L; Parsons MW; Austen KF; Kanaoka Y
J Immunol; 2012 Nov; 189(9):4556-65. PubMed ID: 23002438
[TBL] [Abstract][Full Text] [Related]
35. Molecular cloning and functional characterization of murine cysteinyl-leukotriene 1 (CysLT(1)) receptors.
Martin V; Sawyer N; Stocco R; Unett D; Lerner MR; Abramovitz M; Funk CD
Biochem Pharmacol; 2001 Nov; 62(9):1193-200. PubMed ID: 11705452
[TBL] [Abstract][Full Text] [Related]
36. Studies of receptors and modulatory mechanisms in functional responses to cysteinyl-leukotrienes in smooth muscle.
Bäck M
Acta Physiol Scand Suppl; 2002 Feb; 648():1-55. PubMed ID: 11913222
[TBL] [Abstract][Full Text] [Related]
37. Functional characteristics of cysteinyl-leukotriene receptor subtypes.
Bäck M
Life Sci; 2002 Jun; 71(6):611-22. PubMed ID: 12072150
[TBL] [Abstract][Full Text] [Related]
38. Functional characterisation of receptors for cysteinyl leukotrienes in smooth muscle.
Jonsson EW
Acta Physiol Scand Suppl; 1998 Mar; 641():1-55. PubMed ID: 9597121
[TBL] [Abstract][Full Text] [Related]
39. IL-5 up-regulates cysteinyl leukotriene 1 receptor expression in HL-60 cells differentiated into eosinophils.
Thivierge M; Doty M; Johnson J; Stanková J; Rola-Pleszczynski M
J Immunol; 2000 Nov; 165(9):5221-6. PubMed ID: 11046055
[TBL] [Abstract][Full Text] [Related]
40. Leukotriene D4 induces brain edema and enhances CysLT2 receptor-mediated aquaporin 4 expression.
Wang ML; Huang XJ; Fang SH; Yuan YM; Zhang WP; Lu YB; Ding Q; Wei EQ
Biochem Biophys Res Commun; 2006 Nov; 350(2):399-404. PubMed ID: 17010308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
